491
Patients with inoperable or metastatic colorectal cancer were randomized to receive monthly FU 400 mg/m2/day plus LV 20 mg/m2/day as intravenous push daily for five days, or FU alone.
 Patients with inoperable or metastatic colorectal cancer: Subject; monthly FU 400 mg/m2/day plus LV 20 mg/m2/day as intravenous push daily for five days: Treatment; metastatic colorectal cancer: Treatment.Disorder; inoperable: Treatment.Disorder; 400 mg/m2/day: Treatment.Dosage; 20 mg/m2/day: Treatment.Dosage; FU: Treatment.Drug; LV: Treatment.Drug; intravenous push: Treatment.Route; daily: Treatment.Freq; monthly: Treatment.Freq; five days: Treatment.Duration; FU: Combination.Drug; LV: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 Patients with inoperable or metastatic colorectal cancer: Subject; monthly FU 400 mg/m2/day plus LV 20 mg/m2/day as intravenous push daily for five days: Treatment; metastatic colorectal cancer: Treatment.Disorder; inoperable: Treatment.Disorder; 400 mg/m2/day: Treatment.Dosage; 20 mg/m2/day: Treatment.Dosage; FU: Treatment.Drug; LV: Treatment.Drug; intravenous push: Treatment.Route; daily: Treatment.Freq; monthly: Treatment.Freq; five days: Treatment.Duration; FU: Combination.Drug; LV: Combination.Drug